# OnCo record correct (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/correct/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "correct", "NCT01103323" ;
  schema:name "CORRECT"@en ;
  schema:description "The first pill to lengthen life in bowel cancer after everything else has failed. The gain was six weeks and the hand and foot rash was severe in one patient in six."@en ;
  schema:url <https://onco.cc/trials/correct/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01103323>, <https://doi.org/10.1016/S0140-6736(12)61900-X>, <https://www.nice.org.uk/guidance/ta866>, <https://www.ema.europa.eu/en/medicines/human/EPAR/stivarga> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/antiangiogenic/> ;
  onco:targets <https://onco.cc/targets/vegf/>, <https://onco.cc/targets/braf/> ;
  onco:drugs <https://onco.cc/drugs/regorafenib/> ;
  onco:companies <https://onco.cc/companies/bayer/> ;
  onco:trials <https://onco.cc/trials/concur/> .